CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers
Author
A Bahhnassy
A Kermagoret
+47Â more
A Mencalha
A Thielemann
Adhikesavan Harikrishnan
AJ North
AR Tan
B Ramakrishna
B Zhang
C Parson
CA Kumar
CC Konkankit
CV Garcia
DA Yardley
Didier Desmaele
G Ren
J Ho
JC Su
JM Ferrero
JM Zarzynska
JN Gerson
JP Peyrat
K Alhallak
K Ohl
KL Shamelashvili
L Girnita
L Zeng
M Bartucci
M Conrad
M Diaz
O Bibollet-Bahena
P Collery
P Collery
P Collery
P Collery
P Garnica
P Schmid
Philippe Collery
S Kim
S Santos Bernardes
T Kaur
TJ Key
V Ivanovic
Vijay Veena
X Chen
X Gao
Y Zhou
YF Fu
Z Pei
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref